Zepbound Almost Eliminates Diabetes Risk in Overweight People

People who are overweight or have obesity and have prediabetes may be less likely to develop full-blown diabetes when they take Mounjaro or Zepbound, according to preliminary study results released by drugmaker Eli Lilly.